Considering that normalization of [Na+]serum is pivotal in HF and advanced cirrhosis, vaptans offer a new treatment approach for these diseases sharing a maladaptive AVP response with the syndrome of inappropriate antidiuretic hormone secretion (SIADH). The gene discussed is AVP; the disease is hydrops fetalis.